Internal Medicine, Infectious Disease · Irvington, NJ
NPI
1457710980
Since 2016
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
701 Stuyvesant Ave
Irvington, NJ, 07111
Phone (973) 372-1828
Groups this clinician bills Medicare through
Medicare paid, 2024
$227K
2,767 services
Medicare patients, 2024
513
Average age 75
Drug cost, 2024
$2.4M
10,820 prescriptions
Company payments, 2025
$1,193
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raj Patel was code 99232 (hospital e&m - subsequent), 881 times for 237 patients. In total Raj Patel billed 2,767 services in 22 codes, and Medicare paid $227K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 881 | 237 | $66.22 | $58K |
| 99214 Office E&M - Established | Office | 649 | 191 | $98.93 | $64K |
| 99223 Hospital E&M - Initial | Facility | 306 | 261 | $145.86 | $45K |
| 99233 Hospital E&M - Subsequent | Facility | 190 | 47 | $99.15 | $19K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 150 | 99 | $13.70 | $2,055 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 137 | 32 | $51.14 | $7,006 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 120 | 30 | $39.73 | $4,767 |
| 36415 Venipuncture Blood Collection | Office | 115 | 89 | $8.65 | $995 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 63 | 63 | $140.85 | $8,873 |
| 99222 Hospital E&M - Initial | Facility | 57 | 56 | $109.84 | $6,261 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 20 | 17 | $242.53 | $4,851 |
By year: 2022 $296K for 3,372 services; 2023 $305K for 3,533 services; 2024 $227K for 2,767 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 115 | 89 | $8.65 | $995 |
Medicare prescription drug claims, 2024
In 2024, the drug Raj Patel prescribed most often to Medicare patients was Atorvastatin Calcium, with 892 prescriptions and refills. In total Raj Patel wrote 10,820 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 892 | 2,286 | 347 | $10K |
| Amlodipine Besylate Generic | 597 | 1,523 | 215 | $3,807 |
| Metformin Hcl Generic | 398 | 1,056 | 147 | $3,138 |
| Furosemide Generic | 345 | 857 | 146 | $1,750 |
| Pantoprazole Sodium Generic | 283 | 685 | 104 | $2,944 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 254 | 416 | 104 | $9,827 |
| Metoprolol Succinate Generic | 250 | 688 | 94 | $3,138 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 223 | 608 | 84 | $3,187 |
| Carvedilol Generic | 202 | 545 | 75 | $2,001 |
| Losartan Potassium Generic | 199 | 546 | 69 | $2,023 |
| Methylprednisolone Generic | 194 | 194 | 154 | $1,397 |
| Zolpidem Tartrate Generic | 191 | 191 | 70 | $1,329 |
| Pravastatin Sodium Generic | 166 | 426 | 57 | $1,834 |
| Lisinopril-Hydrochlorothiazide Lisinopril/Hydrochlorothiazide | 160 | 415 | 51 | $1,196 |
| Eliquis Apixaban | 158 | 285 | 44 | $164K |
Brand drugs: 1,650 claims; generic drugs: 9,026 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raj Patel $1,193 ($1,193 in general payments such as food, travel and fees) from 13 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $250.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 8 | $250 |
| Novo Nordisk Inc NVO | 11 | $241 |
| Gilead Sciences, Inc. GILD | 16 | $219 |
| Insmed, Inc. INSM | 9 | $139 |
| Si-Bone, Inc. SIBN | 2 | $131 |
| ViiV Healthcare Company GSK | 3 | $60.08 |
| Theratechnologies Inc. THTX | 2 | $33.7 |
| Amgen Inc. AMGN | 2 | $33.2 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Janssen Biotech, Inc. JNJ | 1 | $16.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.